Abstract Library

Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.

Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.

ENETS Abstract Search

#2850 A Clinical Controlled Observation of Chinese Herbal Decoction (SMLJ01) for Type 1 Gastric Neuroendocrine Neoplasms

Introduction: Type 1 gastric neuroendocrine neoplasms (g-NENs) usually have good prognosis, however, most patients(pts) experience the recurrence after endoscopic resection.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Tan H

Authors: Chen Y, Han D, Zhu J, Chen J, Hu H,

Keywords: type 1 g-NENs, recurrence, Chinese herbs,

#2848 Correlation between Clinicopathological Features and Distant Metastases in Pancreatic Neuroendocrine Neoplasm: A National Multicenter 10-Year Retrospective Study

Introduction: The incidence of pancreatic neuroendocrine neoplasm (PNEN) is increasing, and the prognosis of patients with PNEN is quite different.So, it is of great significance to study the effect of different pathological features on the prognosis of patients with PNEN.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Zhu X, Yang H, Lu H, Shi S, Yihebali C,

Keywords: Pancreatic Neuroendocrine Neoplasm, Distant Metastases, Retrospective Study,

#2234 High Rate of Copy-Number Alterations in Gastrointestinal and Pancreatic Neuroendocrine Tumors with Unidentified Driver Mutations

Introduction: The driving genetic alteration leading to neuroendocrine tumor (NET) development has been reported for primary tumors of pancreatic origin, but not for metastases. Moreover, even for primary tumor a significant “dark matter” remains to be explored.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Tirosh A

Authors: Tirosh A, Killian J, Zhu Y, Neychev V, Meltzer P,

Keywords: GEP-NET, Driver mutation, Copy-number, Metastases,

#1743 FOLFIRI Regimen with or without Bevacizumab As Second-Line Therapy Showed Activity in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Carcinoma

Introduction: Metastatic disease of GEP-NEC is tough condition in clinical practice. And the role of the second-line therapy remains unknown

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: ZHIYU C

Authors: Chen Z, Zhao X, Wang C, Zhang W, Zhu X,

Keywords: NEC, FOLFIRI, bevacizumab ,

#1390 Ectopic Malignant Insulinoma with Multiple Liver Metastases: A Case Report

Introduction: Malignant insulinoma arising from ectopic pancreas is very rare.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Liu Q

Authors: Liu Q, Luo J, Li C, Zhu Z, Tan H,

Keywords: ectopic malignant insulinoma, octreotide, everolimus, 68Ga-exendin-4 PET/CT,